Loading…
BillionToOne, Inc. is projected to rise to $188.88 by 2027, a +49% move from its current price of $126.77. BLLN is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $122.48 | $126.79 | $131.25 | +0.02% |
| Jul 13 | $120.76 | $126.81 | $133.16 | +0.03% |
| Jul 14 | $119.46 | $126.83 | $134.65 | +0.05% |
| Jul 15 | $118.37 | $126.85 | $135.93 | +0.06% |
| Jul 16 | $117.43 | $126.87 | $137.06 | +0.08% |
| Jul 17 | $116.58 | $126.89 | $138.10 | +0.09% |
| Jul 18 | $115.81 | $126.90 | $139.06 | +0.11% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $115.81 | $126.90 | $139.06 | +0.11% |
| Week 2 | $111.63 | $127.04 | $144.58 | +0.21% |
| Week 3 | $108.54 | $127.17 | $149.00 | +0.32% |
| Week 4 | $106.03 | $127.31 | $152.86 | +0.42% |
| Week 5 | $103.87 | $127.44 | $156.36 | +0.53% |
| Week 6 | $101.98 | $127.58 | $159.61 | +0.64% |
| Week 7 | $100.27 | $127.71 | $162.67 | +0.74% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
BillionToOne, Inc. is a precision diagnostics company that quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection.
It offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a list of mutations that are present in the tumor and types of mutations detected that include deletions, insertions, and point mutations; and Northstar Response, a methylation-based assay that quantifies the amount of cancer at the single molecule level without requiring a tissue biopsy, enabling real-time monitoring of patient response to therapy with unprecedented precision.
BillionToOne, Inc. was incorporated in 2016 and is headquartered in Menlo Park, California.
BillionToOne, Inc. (BLLN) currently trades at $127.97 per share and has a market capitalization of $5.89B. It ranks 1275 among tracked assets and sits in the Healthcare category.
The stock’s near-term outlook reflects a neutral stance for 2026, with a 2026 average price of $127.97, a low of $64.03 and a high of $189.24, and an ROI of 0%. From 2027 onward, the forecast turns bullish with rising averages and meaningful upside potential, culminating in a 2050 max price of $6,517.26 and a long-run upside implied by the sequence of yearly forecasts.
Overall, the forecast pathway shows continued upside, including a 2030 average price of $351.52 and a 2050 maximum price of $6,517.26, underscoring a long-run bullish trajectory while recognizing the estimates are not guarantees.
A major floor 49.5% below — a decisive break under it would weaken the trend.
The nearest floor, 28.1% below — buyers have tended to step in here.
Price is pressing into resistance (0.9% away) — a breakout level to watch.
A major ceiling 20.0% above — clearing it would confirm fresh momentum.
Key BLLN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BLLN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $123.36 | Buy | $123.99 | Buy |
| MA 10 | $121.80 | Buy | $120.55 | Buy |
| MA 20 | $112.65 | Buy | $114.35 | Buy |
| MA 50 | $98.75 | Buy | $102.97 | Buy |
| MA 100 | $88.55 | Buy | $96.39 | Buy |
| MA 200 | — | Neutral | — | Neutral |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 67.07 | Neutral |
| Stoch RSI (14) | 81.81 | Sell |
| CCI (20) | 102.85 | Buy |
| Williams %R (14) | -4.40 | Info |
| MACD (12,26,9) | 0.77 | Buy |
| ROC (12) | 21.57 | Buy |
| Bollinger %B (20,2) | 0.86 | Neutral |
| Stochastic %K (14) | 95.60 | Sell |
| TRIX (15) | 1.03 | Buy |
| Awesome (5,34) | 18.09 | Buy |
| Ultimate (7,14,28) | 66.38 | Neutral |
| Momentum (10) | 14.53 | Buy |
| Aroon Osc (25) | 84.00 | Buy |
| Hull MA (9) | 125.02 | Buy |
| ADX (14) | 24.77 | Buy |
| ATR (14) | 3.59 | Info |
The 30-day technical picture is bullish with a rising trend in the near term. The RSI(14) is 70, signaling strong momentum, and the 50-day simple moving average sits at $97.78, providing a near-term support framework.
Immediate support is noted at $91.02 and resistance at $127.97, with the 30-day range ranging from a low of $101.22 to a high of $161.79. Annualized volatility sits around 70%, indicating elevated price movement over the period.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $64.03 | $126.77 | $186.67 | 0% | Neutral | |
| $137.81 | $188.88 | $279.72 | +49% | Bullish | |
| $173.26 | $251.81 | $396.81 | +99% | Bullish | |
| $204.67 | $312.73 | $516.84 | +147% | Bullish | |
| $217.48 | $347.73 | $597.75 | +174% | Bullish | |
| $238.40 | $397.66 | $707.14 | +214% | Bullish | |
| $256.17 | $444.90 | $815.27 | +251% | Bullish | |
| $264.12 | $476.83 | $897.62 | +276% | Bullish | |
| $362.36 | $679.27 | $1,310.49 | +436% | Bullish | |
| $423.31 | $823.30 | $1,624.66 | +549% | Bullish | |
| $586.28 | $1,302.84 | $2,821.13 | +928% | Bullish | |
| $1,269.63 | $2,821.40 | $6,489.21 | +21.3x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $64.03 | $126.77 | $159.70 | +0.00% |
| August 2026 | $109.33 | $132.28 | $166.60 | +4.35% |
| September 2026 | $104.79 | $128.53 | $165.16 | -2.84% |
| October 2026 | $105.50 | $130.93 | $171.10 | +1.87% |
| November 2026 | $110.27 | $138.22 | $183.17 | +5.57% |
| December 2026 | $109.91 | $139.07 | $186.67 | +0.61% |
Click any year to see its month-by-month BLLN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, BLLN is projected to trade between $64.03 and $186.67, averaging $126.77 — a potential gain of 0% from today's $126.77. A consolidation phase looks the most probable path here.
BillionToOne, Inc.'s 2027 outlook centres on $188.88, within a $137.81 to $279.72 range. That is up +49% on the projected 2026 average. That marks a +49% change versus current levels. Momentum favours further upside here.
By 2028, BLLN could reach as high as $396.81, with a base case around $251.81 and support toward $173.26 — roughly +99% from $126.77. Buyers look set to stay in control over this stretch.
Expect BLLN to range from $204.67 to $516.84 through 2029. The $312.73 average target implies a +147% move from current prices. That is up +24% on the projected 2028 average. Momentum favours further upside here.
The BLLN price prediction for 2030 points to an average of $347.73 (low $217.48, high $597.75) — a potential gain of +174% on today's $126.77. Buyers look set to stay in control over this stretch.
In 2031, BLLN is projected to trade between $238.40 and $707.14, averaging $397.66 — a potential gain of +214% from today's $126.77. That is up +14% on the projected 2030 average. Momentum favours further upside here.
BillionToOne, Inc.'s 2032 outlook centres on $444.90, within a $256.17 to $815.27 range. That is up +12% on the projected 2031 average. That marks a +251% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, BLLN could reach as high as $897.62, with a base case around $476.83 and support toward $264.12 — roughly +276% from $126.77. Momentum favours further upside here.
Expect BLLN to range from $362.36 to $1,310.49 through 2034. The $679.27 average target implies a +436% move from current prices. That is up +42% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The BLLN price prediction for 2035 points to an average of $823.30 (low $423.31, high $1,624.66) — a potential gain of +549% on today's $126.77. Momentum favours further upside here.
In 2040, BLLN is projected to trade between $586.28 and $2,821.13, averaging $1,302.84 — a potential gain of +928% from today's $126.77. That is up +58% on the projected 2035 average. Buyers look set to stay in control over this stretch.
BillionToOne, Inc.'s 2050 outlook centres on $2,821.40, within a $1,269.63 to $6,489.21 range. That is up +117% on the projected 2040 average. That marks a +21.3x change versus current levels. Momentum favours further upside here.
Investing $1,000 in BLLN today (≈ 7.888302 BLLN) could be worth
$22,256.02
+$21,256.02 (+2126%) by 2050 · US Dollar
Based on the average projected BLLN price of $2,821.4 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BLLNwould be worth at today's price.
$1,000 invested in BLLN on Nov 6, 2025 (≈ 9.179365 BLLN) would be worth
$1,163.67
+$163.67 (+16.4%) today · 1.16× · US Dollar
Based on a BLLN entry price of $108.94 vs. today's $126.77.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $120.35 | $1,053.34 | +5.3% |
| 1 month ago | $99.26 | $1,277.15 | +27.7% |
| 3 months ago | $81.13 | $1,562.55 | +56.3% |
| 6 months ago | $99.15 | $1,278.57 | +27.9% |
| All time ago | $108.94 | $1,163.67 | +16.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BLLN forecast.
Our base-case forecast reaches $250.00 around 2028.
Implied market cap at $250.00: $10.36B
The multi-year forecast paints a bullish arc across the horizon. For 2026 the avg price is $127.97 with an ROI of 0% (neutral sentiment). Beyond 2026, the model projects a steady climb in average prices and substantial ROI: 2027 avg $192.29 (ROI 50.3%), 2028 avg $255.99 (ROI 100%), 2029 avg $316.41 (ROI 147.3%), 2030 avg $351.52 (ROI 174.7%), 2031 avg $401.10 (ROI 213.4%), 2032 avg $447.48 (ROI 249.7%), 2033 avg $481.95 (ROI 276.6%), 2034 avg $690.91 (ROI 439.9%), 2035 avg $833.44 (ROI 551.3%), 2040 avg $1,322.89 (ROI 933.8%), and 2050 avg $2,833.59 (ROI 2114.3%).
The bearish-to-bullish momentum culminates with a 2050 max price of $6,517.26 and a bullish sentiment throughout.
These figures are estimates of future price levels and are not guarantees. They illustrate a potential bullish trajectory with substantial upside over the long term, alongside inherent uncertainties and market risks that can affect outcomes.
Tap a question to reveal the answer.
The forecast shows 2030 with an average price of $351.52, a minimum of $217.32, a maximum of $610.05, and an ROI of 174.7% with a bullish sentiment.
Near term is neutral for 2026 (avg $127.97, ROI 0) but the outlook from 2027 onward is bullish with rising averages and positive ROI (e.g., 50.3% in 2027 and higher in subsequent years), indicating upside potential while acknowledging uncertainty.
Yes. The forecast shows 2034 with a max of $1,348.52 and 2035 with a max of $1,664.52, followed by higher ceilings such as $2,903.42 in 2040 and $6,517.26 in 2050.
The sentiment is bullish with RSI(14) at 70. The 50-day SMA is $97.78, with support at $91.02 and resistance at $127.97. The 30-day price range runs from $101.22 to $161.79.
Current price is $127.97 and market cap is $5.89B, with a rank of 1275.
BillionToOne, Inc. Community Discussion
0Share your BillionToOne, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.